NDC 55111-617 – Eszopiclone

Eszopiclone 3 mg/1 · Tablet, Coated · Oral

Human Prescription Drug DEA schedule CIV 1 recall

Product NDC55111-617

Product details

Brand name
Eszopiclone
Generic name
Eszopiclone
Labeler
Dr. Reddy's Laboratories Limited
Dosage form
Tablet, Coated
Route
Oral
Marketing category
ANDA · ANDA091024
Marketed since
April 15, 2014
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Eszopiclone →

Package NDC codes (5)

Package NDCDescriptionSince
55111-617-01100 TABLET, COATED in 1 BOTTLE (55111-617-01)Apr 15, 2014
55111-617-05500 TABLET, COATED in 1 BOTTLE (55111-617-05)Apr 15, 2014
55111-617-099 BLISTER PACK in 1 CARTON (55111-617-09) / 10 TABLET, COATED in 1 BLISTER PACK (55111-617-79)Apr 15, 2014
55111-617-3030 TABLET, COATED in 1 BOTTLE (55111-617-30)Apr 15, 2014
55111-617-9090 TABLET, COATED in 1 BOTTLE (55111-617-90)Apr 15, 2014

Recalls mentioning this NDC

Other Eszopiclone products